The North American injection pen market is anticipated to grow at a CAGR of 6.2% over the forecast period. The market is primarily driven by the presence of a large pool of diabetic patients in the region. As per the IDF, in North America, the prevalence of diabetes is approximately 13.3% of the total adult population in the region which is projected to reach up to 14.2% by 2030 and further reach up to 15% by 2045. Increased prevalence of diabetes creates demand for insulin pen and hence insulin provides growth opportunities for the market in the forecast period.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/north-american-injection-pen-market
In addition, high awareness amongst the people related to the availability of various treatment products such as advanced insulin pen is further anticipated to contribute to the growth of the market. Further, significant support from governments such as reimbursements for the government and private insurers is readily available within the region which also promotes the growth of the market over the forecast period.
For instance, there are supportive government initiatives in Canada concerning the awareness about diabetes among Canadians. In June 2019, LMC and Diabetes Canada launched the Canadian Diabetes Prevention Program (CDPP) regarding the awareness of diabetes treatment among the citizens in the country. Hence, such aforementioned factors are likely to support the growth of the market over the forecast period.
North America Injection Pen Market – Segmentation
By Type
- Reusable
- Disposable
By Disorder Type
- Autoimmune Disorders
- Hormonal Disorders
- Orphan Diseases
- Others
North America Injection Pen Market – Countries Covered
- United States
- Canada
A full report of North American Injection Pen Market is available at: https://www.omrglobal.com/industry-reports/north-american-injection-pen-market
North American Injection Pen Market– Segment by Region
- United States
- Canada
Company Profiles
- AstraZeneca Plc
- Becton, Dickinson & Co.
- Copernicus
- Eli Lilly and Co.
- Hoffmann-La Roche Ltd.
- Gerresheimer AG
- GlaxoSmithKline Plc
- Novartis International AG
- Novo Nordisk A/S
- Pfizer Inc.
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
Visit more report at
https://www.linkedin.com/pulse/scaffold-technology-market-size-trends-latest-arti-vishwakarma-mlsof/